InvestorsHub Logo
Followers 5
Posts 2466
Boards Moderated 0
Alias Born 08/16/2016

Re: klimanjaro post# 4796

Friday, 12/09/2016 11:57:43 AM

Friday, December 09, 2016 11:57:43 AM

Post# of 20617
klimanjaro, when and if fluticare is approved, do you think it will result in a trading halt? I can't seem to get anyone to answer that question...(Do not be afraid to be right or wrong, just someone give me an opinion or better yet, a factual answer.)

Costco stock didn't have a trading halt when they put there generic fluticare OTC...

GSK didn't have a trading halt when flonase was approved for OTC.

Don't people on here understand that INNV isn't a real pharma? INNV isn't trying to cure cancer...It's more of a nutraceuatical, vitamin supplement company...

Fluticare isn't life saving, heck it's barely life enhancing, so why do these idiots think there will be a trading halt on approval?

Fluticare does not have an orphan designation either...

There are many types of Fluticares already out there!

Why do these idiots think that when Fluticare is approved that the PPS will jump up to .75 overnight?

I really, really don't think Fluticare approval will result in any increased PPS! It will take several quarters of full sales to help the PPS and it won't even help much, because the market is already flooded and because the profit margin will be so low.

In short, Fluticare approval is a joke and here's why...

1. Approval has taken too long.
2. The market is already flooded with generic OTCs.
3. If approved, no trading halt.
4. If approved, no increase in PPS.
5. If approved, no increase in PPS until after several quarters and even then it won't be much, because the profit margin would be so low.
6. Big pharma is not interested in buying INNV, because INNV isn't really a pharma...
7. INNV is a real joke and should be renamed to INNV-joke-company-with-gag-products.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.